Brief: Matinas Biopharma - Btig Terminates Sales Agreement With Matinas Biopharma Holdings, Effective Immediately On July 23, 2026 - SEC Filing
24/07/2026 22:36
BRIEF-Matinas Biopharma - Btig Terminates Sales Agreement With Matinas Biopharma Holdings, Effective Immediately On July 23, 2026 - SEC Filing July 24 (Reuters) - Matinas BioPharma Holdings Inc MTNB.A:
MATINAS BIOPHARMA - BTIG TERMINATES SALES AGREEMENT WITH MATINAS BIOPHARMA HOLDINGS, EFFECTIVE IMMEDIATELY ON JULY 23, 2026 - SEC FILING
MATINAS BIOPHARMA - INCURS NO TERMINATION PENALTIES OR EXPENSES FROM SALES AGREEMENT TERMINATION - SEC FILING
Source text: [ID:n0001493152-26-034601]
Further company coverage: MTNB.A
((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on Matinas BioPharma Holdings
See all newsBrief: GH Power Signs Multi-Year Hydrogen Offtake Agreement With Change Energy For Hamilton Facility Output
Brief: Gh Power And Tkms Continue To Explore Clean Energy Collaboration In Support Of Canada’S Future Patrol Submarine Project
Brief: Matinas Biopharma - Btig Terminates Sales Agreement With Matinas Biopharma Holdings, Effective Immediately On July 23, 2026 - SEC Filing
Brief: Matinas Biopharma Receives Notice Of Non-Compliance With NYSE American Continued Listing Standards And Acceptance Of Plan To Regain Compliance
Brief: Matinas Biopharma - May Offer Securities Up To $150 Million - SEC Filing